当前位置：
X-MOL 学术
›
Stem Cell Res. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin
Stem Cell Research & Therapy ( IF 7.5 ) Pub Date : 2021-02-12 , DOI: 10.1186/s13287-021-02196-x Ameneh Jafari 1, 2 , Mostafa Rezaei-Tavirani 2 , Behrouz Farhadihosseinabadi 3 , Hakimeh Zali 4 , Hassan Niknejad 5
Stem Cell Research & Therapy ( IF 7.5 ) Pub Date : 2021-02-12 , DOI: 10.1186/s13287-021-02196-x Ameneh Jafari 1, 2 , Mostafa Rezaei-Tavirani 2 , Behrouz Farhadihosseinabadi 3 , Hakimeh Zali 4 , Hassan Niknejad 5
Affiliation
Cancer is a leading cause of death in both developed and developing countries, and because of population growth and aging, it is a growing medical burden worldwide. With robust development in medicine, the use of stem cells has opened new treatment modalities in cancer therapy. In adult stem cells, mesenchymal stem cells (MSCs) are showing rising promise in cancer treatment due to their unique properties. Among different sources of MSCs, human amniotic fluid/membrane is an attractive and suitable reservoir. There are conflicting opinions about the role of human amniotic membrane/fluid mesenchymal stem cells (hAMSCS/hAFMSCs) in cancer, as some studies demonstrating the anticancer effects of these cells and others suggesting their progressive effects on cancer. This review focuses on recent findings about the role of hAMSCs/hAFMSCs in cancer treatment and summarizes the suppressing as well as promoting effects of these cells on cancer progression and underling mechanisms.
更新日期：2021-02-12
京公网安备 11010802027423号